Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19

NCT05276375 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Bronchipret

Sponsor

Dr. Frank Behrens

Collaborators

[object Object]